Now that COVID-19 proved the value of this new kind of vaccine, what other previously intractable diseases might be conquered with it? More
Bio & Life Sciences Healthcare The Pandemic
mRNA Vaccines Protect Us from COVID-19. What Else Could They Do?
Bio & Life Sciences Healthcare
New Report: Genomics Drives Economic Growth
The field of human genomics has risen from inauspicious beginnings to become an economic powerhouse, and continues to increase our understanding of human health and how to cure diseases. More
Analytics & Data Artificial Intelligence Bio & Life Sciences Sustainable Development Goals
Can Augmented Intelligence Help Save the Planet?
Only through global collaboration can we turn back the clock on climate change. A combination of human expertise and AI could get us there. More
Bio & Life Sciences Healthcare The Pandemic
‘An Infection Anywhere Is Potentially an Infection Everywhere’: Preparing for the Next Pandemic
Experts are already distilling lessons from the COVID-19 pandemic to inform our response to future outbreaks. More
Bio & Life Sciences Healthcare The Pandemic
6 Things You Don’t Know About Pfizer’s COVID-19 Vaccine
For starters, it was one of four mRNA candidates. Check out this behind-the-scenes look at how Pfizer and BioNTech developed one of the world’s most effective vaccines for the SARS-CoV-2 virus. More
Bio & Life Sciences Innovation Sustainable Development Goals
Tech and Innovation Offer Promise for the World’s Most Water-Challenged Regions
Many water sources are drying up, becoming more polluted, or both. Water-intensive industry, agriculture, and energy generation are growing to meet the needs of an ever-expanding population, resulting in further water scarcity and stress. What can we do to solve water? More
Bio & Life Sciences The Pandemic
This ‘Covidgilante’ Says Vaccines Work on ‘Scariants’
Cardiologist, genomics expert, and digital healthcare advocate Dr. Eric Topol is obsessed with Covid and a major force in the U.S. response. He explains his optimism at next week’s conference. More
Bio & Life Sciences Healthcare The Pandemic
You’re Vaccinated — Now What?
Confused about what precautions are needed after getting the COVID-19 vaccine? You’re not alone. Here’s the latest expert advice. More
Bio & Life Sciences Healthcare The Pandemic
Preprints: How Science Moved So Fast During COVID-19
A quiet revolution in how scientists report their discoveries greased the skids for the super-fast progress we’ve seen in the pandemic. More
Bio & Life Sciences Energy & Green Tech Manufacturing
Nature + Tech = Sustainable Fashion
In the future textile manufacturing will be part farm, part chemistry lab, and part factory. Nature and high tech don't have to be at odds. More
Bio & Life Sciences Healthcare The Pandemic
Annual Vaccines May Be Necessary: Lessons from the COVID-19 Genome
The genomic field continues to shed light on COVID-19. The latest: vaccination frequency, new therapy options, and unexpected mutations in the virus. More
Bio & Life Sciences Healthcare Innovation
Drug Researchers Need to Learn to “Fail Fast”
Failure is never the goal in healthcare. But ‘failing fast’ is not at odds with healthcare’s commitment to the patient. On the contrary, it reinforces the critical path of putting the patient first. More
Bio & Life Sciences Healthcare The Pandemic
Why the U.S. Needs More COVID-19 Genome Sequencing
Other countries can spot new variants because they’re actively looking for them. But the U.S. has spent a year with its head in the sand. More
Bio & Life Sciences Healthcare
Research Project Seeks Cancer’s Achilles Heel
By looking at cancer as an engineering problem instead of a medical one, scientists are homing in on vulnerabilities that may lead to new ways to knock out tumors. More
Bio & Life Sciences Healthcare The Pandemic
mRNA Vaccines for COVID-19: What You Need to Know
Pfizer and Moderna's astonishingly promising vaccines were made possible by a new scientifiic approach. Here’s a primer on how mRNA vaccines work and why we need them now. More
Bio & Life Sciences The Pandemic
COVID-19 Testing: Good, Bad, and Downright Frustrating
Even dramatically increased testing capacity has been no match for poor strategy and misdirected deployment of tests in the U.S. More
Analytics & Data Bio & Life Sciences The Pandemic
Could a Schizophrenia Treatment Conquer COVID-19?
Scientists are analyzing previously approved drugs to see if they have any effect against the SARS-CoV-2 virus. They might be onto something. More
Bio & Life Sciences Healthcare Resilience Techonomy Events
Making the World a Healthier Place through Digital Health
Moderated by W2O’s Aaron Strout, panel participants include Melissa Opraseuth, Chief Operating Officer at par8o and Jennifer Lavanture, Vice President of Business Development at MedRhythms. Panelists will discuss how the technology’s promise of advancing healthcare is being realized at both their companies and how this sector will evolve over the next couple of years. More
Analytics & Data Bio & Life Sciences Healthcare
How Google Thinks About Digital Health
A leader in some of Alphabet’s health-focused initiatives recently offered an update on ways the search and data giant can use information and digital tools to improve outcomes for individuals and society. More
Bio & Life Sciences The Pandemic
Science Is What Determined a Successful Public Response to COVID-19
Some leaders saw that flattening the curve wouldn’t work against the pandemic. Others were reluctant to test at all. Scientific data made the difference between responses that worked, and those that didn’t. More
Newsletter